BioSpace News Archive

The National Spine Health Foundation (NSHF) leads the national conversation in spine health by launching its newly designed website in support of its mission of empowering patients with knowledge and hope.

MDVIP, the national leader in affordable personalized healthcare with a network of nearly 1,000 primary care physicians, has been recognized as a Great Place to Work-Certified® company for a second consecutive year.

Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for Q3 2019.

Medicine Man Technologies, Inc. (OTCQX: MDCL) (“Medicine Man Technologies” or the “Company”) today announced the appointment of Nancy Bush Huber as the Company’s Vice President (VP) of Finance.

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), today announced that Derrick Li, Head of Strategy for the Company, will present at Baird’s 2019 Global Healthcare Conference to be held at the InterContinental New York Barclay in New York, NY on Thursday, September 5, 2019 at 9:40am ET.

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming investor conferences.

Today, the AmerisourceBergen Foundation (the Foundation), an independent not-for-profit charitable giving organization dedicated to supporting health-related causes, announced it has partnered with more than 20 organizations to help prevent and curb the harmful effects of prescription drug misuse, especially among youth.

Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, today announced that senior management will present company overviews and conduct one-on-one investor meetings at the following healthcare investor conferences:

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that the company will participate in two upcoming investor conferences in New York City.

Catasys, Inc. (NASDAQ: CATS) (“Catasys” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that Mr. Terren Peizer, the Company’s Chairman and CEO, is scheduled to participate in one-on-one and small group meetings at the 4th annual Dougherty & Company Institutional Investor Conference being held Thursday, September 5, 2019, at the Millennium Hotel in Minneapolis.